INFORMACIONES PSIQUIÁTRICAS 246

Informaciones Psiquiátricas 2022 - n.º 246 61 32. Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-genera- tion antipsychotics. Schizophr Res. 2013 Apr;145(1-3):116-9. doi: 10.1016/j. schres.2012.12.027. Epub 2013 Jan 31. PMID: 23375624. 33. Torre DL, Falorni A. Pharmacological causes of hyperprolactinemia. Ther Clin Risk Manag. 2007 Oct;3(5):929-51. PMID: 18473017; PMCID: PMC2376090. 34. Peuskens J, Pani L, Detraux J, De Hert M. The effects of novel and newly ap- proved antipsychotics on serum prolac- tin levels: a comprehensive review. CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3. PMID: 24677189; PMCID: PMC4022988. 35. Meltzer HY. Long-term effects of neu- roleptic drugs on the neuroendocrine system. Adv Biochem Psychopharmacol. 1985; 40:59-68. PMID: 2862768. 36. Holt RI, Peveler RC. Antipsychotics and hyperprolactinaemia: mechanisms, con- sequences and management. Clin Endo- crinol (Oxf). 2011 Feb;74(2):141-7. doi: 10.1111/j.1365-2265.2010.03814. x. PMID: 20455888. 37. Hernández A.I., Montejo AL, Prieto N, Sánchez S, Gallego MT, Bote B, et al. EPA: 1694 Antipsychotics and prolac- tin. Study of prevalence and associa- ted sexual dysfunction. Eur Psychia- tr. 2014;29(Supp 1):1. Disponible en :htp://dx.doi.org/10.1016/S0924- 9338(14)78837-6. 38. Bonete Llácer JM, Martínez Hortelano A, Richart Albelda B. Hyperprolacti- nemia in psychotic patients treated in monotherapy with long-acting injec- table antipsychotics. Int J Psychiatry Clin Pract. 2019 Sep;23(3):189-193. doi: 10.1080/13651501.2019.1576905. Epub 2019 Mar 8. PMID: 30848967. HIPERPROLACTINEMIA INDUCIDA POR ANTIPSICÓTICOS EN RESIDENTES DE UN CENTRO SOCIOSANITARIO